Therapeutics targeting ADP-ribose Hydrolases
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
600
NCT06361095
Confirmatory Efficacy Trial of Attention Bias Modification for Depression
Phase: Early Phase 1
Role: Collaborator
Start: May 1, 2024
Completion: May 1, 2028
Loading map...